EcoDrugPlus

Ensembl ID : ENSCVAG00000011429
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSCVAG00000007027
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSCVAG00000006827
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSCVAG00000011551
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSCVAG00000012732
Gene Symbol: -
Cross references: -
292 Possible Orthologues:

Ensembl ID : ENSCVAG00000023128
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSCVAG00000015310
Gene Symbol: -
Cross references: -
175 Possible Orthologues:

Ensembl ID : ENSCVAG00000013462
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSCVAG00000017845
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSCVAG00000022476
Gene Symbol: -
Cross references: -
141 Possible Orthologues:

Ensembl ID : ENSCVAG00000022497
Gene Symbol: -
Cross references: -
385 Possible Orthologues:

Ensembl ID : ENSCVAG00000022034
Gene Symbol: -
Cross references: -
168 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).